Alpidem is a member of imidazoles. ALPIDEM is a small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in at least one region. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Alpidemum and Ananxyl. Its PubChem CID is 54897.
Alpidem
| CAS No | 82626-01-5 |
|---|---|
| Molecular Formula | C21H23Cl2N3O |
| Molecular Weight | 404.3 g/mol |
| Synonyms | 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Alpidem is a member of imidazoles. ALPIDEM is a small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in at least one region. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin.
The listed CAS number is 82626-01-5.
The listed molecular formula is C21H23Cl2N3O.
The listed molecular weight is 404.3 g/mol.
2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide.
The source lists Alpidemum and Ananxyl.